Component

Iodide concentration in airway secretions

Study-specific endpoint; inspect claim context for model and measurement.

2 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

Read recorded mechanisms Open recursive mind map

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What acts on it

  1. The same human KI exposure increased iodide in upper-airway secretions.

    Potassium iodide → Iodide concentration in airway secretions source_derived_draftungraded
    Experimental context and source evidence
    experimental_model
    Primary airway epithelial cultures and human oral-KI exposure; separate experimental arms.
    exposure_category
    Study-specific exposure, including pharmacological and in-vitro conditions; normal is the schema fallback outside the three availability categories.
    limitations
    Culture antiviral activity and human secretion measurements do not establish prevention or treatment of human infection.
    nutrient_topic
    Potassium iodide research collection; shared-anion and comparator studies are not all KI interventions. · Potassium iodide
    plain_language
    Iodide reached airway secretions, beyond the thyroid.
    primary_references
    Enhancement of respiratory mucosal antiviral defenses by the oxidation of iodide. · 2011 · https://pubmed.ncbi.nlm.nih.gov/21441383/ · DOI 10.1165/rcmb.2010-0329oc

    Potassium iodide: thyroid and non-thyroid mechanisms, interactions and discovery questions (2026-09-18) · lines 64–70

    AI-assisted research curation; primary-study references, chemical references and label statements individually identified. Not publisher full text. · supports · Primary airway epithelial cultures and human oral-KI exposure; separate experimental arms. · source_derived_draft · unverified_draft

    ## ki-air-secretions Iodide reached airway secretions, beyond the thyroid. The same human KI exposure increased iodide in upper-airway secretions. Model: Primary airway epithelial cultures and human oral-KI exposure; separate experimental arms. Limitations: Culture antiviral activity and human secretion measurements do not establish prevention or treatment of human infection. Evidence location: Primary abstract Enhancement of respiratory mucosal antiviral defenses by the oxidation of iodide. · 2011 · https://pubmed.ncbi.nlm.nih.gov/21441383/ · DOI 10.1165/rcmb.2010-0329oc
    Complete structured claim and evidence

  2. KI raised lamb airway-surface-liquid iodide about tenfold, to approximately thirtyfold the serum concentration.

    Potassium iodide → Iodide concentration in airway secretions source_derived_draftungraded
    Experimental context and source evidence
    experimental_model
    Newborn and three-week-old lamb RSV experiments; oral KI given by intragastric gavage.
    exposure_category
    Study-specific exposure, including pharmacological and in-vitro conditions; normal is the schema fallback outside the three availability categories.
    limitations
    Animal disease model; no human antiviral efficacy established. LPO inhibition supports pathway involvement, not an exclusively LPO mechanism.
    nutrient_topic
    Potassium iodide research collection; shared-anion and comparator studies are not all KI interventions. · Potassium iodide
    plain_language
    Airway secretions concentrated iodide after oral KI.
    primary_references
    Increased concentration of iodide in airway secretions is associated with reduced respiratory syncytial virus disease severity. · 2014 · https://pubmed.ncbi.nlm.nih.gov/24053146/ · DOI 10.1165/rcmb.2012-0529oc

    Potassium iodide: thyroid and non-thyroid mechanisms, interactions and discovery questions (2026-09-18) · lines 96–102

    AI-assisted research curation; primary-study references, chemical references and label statements individually identified. Not publisher full text. · supports · Newborn and three-week-old lamb RSV experiments; oral KI given by intragastric gavage. · source_derived_draft · unverified_draft

    ## ki-lamb-iodide Airway secretions concentrated iodide after oral KI. KI raised lamb airway-surface-liquid iodide about tenfold, to approximately thirtyfold the serum concentration. Model: Newborn and three-week-old lamb RSV experiments; oral KI given by intragastric gavage. Limitations: Animal disease model; no human antiviral efficacy established. LPO inhibition supports pathway involvement, not an exclusively LPO mechanism. Evidence location: Primary abstract Increased concentration of iodide in airway secretions is associated with reduced respiratory syncytial virus disease severity. · 2014 · https://pubmed.ncbi.nlm.nih.gov/24053146/ · DOI 10.1165/rcmb.2012-0529oc
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards